デフォルト表紙
市場調査レポート
商品コード
1651702

ナノメディシンの市場規模、シェア、成長分析:製品タイプ別、用途別、適応症別、モダリティ別、地域別 - 産業予測 2025~2032年

Nanomedicine Market Size, Share, and Growth Analysis, By Product Type (Nano Molecules, Nanoparticles), By Application (Vaccines, Regenerative Medicines), By Indication, By Modality, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ナノメディシンの市場規模、シェア、成長分析:製品タイプ別、用途別、適応症別、モダリティ別、地域別 - 産業予測 2025~2032年
出版日: 2025年02月06日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ナノメディシン市場規模は2023年に1,994億米ドルとなり、予測期間(2025-2032年)のCAGRは12.4%で、2024年の2,241億3,000万米ドルから2032年には5,709億8,000万米ドルに成長する見通しです。

ナノメディシン市場は、満たされていない医療ニーズに対応し、患者の転帰を向上させる革新的なソリューションの開発に注力していることから、大きな成長が見込まれています。薬物送達の改善、バイオアベイラビリティ、標的治療などの利点を持つナノメディシンは、高度なナノテクノロジーを活用して、より正確で個別化された治療を実現します。促進要因としては、新規医療用途を可能にするナノテクノロジーの進歩が挙げられるが、一方で高い開発コストや生産規模の拡大の複雑さといった課題を克服する必要があります。こうしたハードルにもかかわらず、この市場には、特に慢性疾患の蔓延が高まる中、標的薬物送達システムと診断において、十分なビジネスチャンスがあります。全体として、米国のナノメディシン市場は持続的な成長を遂げ、革新的なソリューションを通じてヘルスケア提供に変革をもたらすと期待されています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

ナノメディシン市場規模:製品タイプ別& CAGR(2025-2032)

  • 市場概要
  • ナノ分子
  • ナノ粒子
  • リポソーム
  • ポリマーおよびポリマー薬物複合体
  • ハイドロゲルナノ粒子
  • デンドリマー
  • ナノシェル
  • ナノチューブ
  • ナノデバイス

ナノメディシン市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • ワクチン
  • 再生医療
  • 診断画像
  • ドラッグデリバリー
  • インプラント
  • 体外画像
  • 体外診断
  • 治療薬
  • その他

ナノメディシン市場規模:適応症別& CAGR(2025-2032)

  • 市場概要
  • 腫瘍性疾患
  • 感染症
  • 心血管疾患
  • 整形外科疾患
  • 神経疾患
  • 泌尿器疾患
  • 眼科疾患
  • 免疫疾患
  • 抗炎症疾患
  • 感染症予防
  • その他

ナノメディシン市場規模:モダリティ別& CAGR(2025-2032)

  • 市場概要
  • 治療
  • 診断

ナノメディシン市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Imina Technologies SA(Switzerland)
  • NANONICS IMAGING Ltd.(U.S.)
  • Altair Nanotechnologies Inc.(U.S.)
  • Bruker Corporation(U.S.)
  • Kleindiek Nanotechnik GmbH(Germany)
  • eSpin Technologies, Inc.(U.S.)
  • Advanced Nano Products Co., Ltd.(South Korea)
  • Applied Nanotech, Inc.(U.S.)
  • Biosensors International Group, Ltd.(Singapore)
  • Thermo Fisher Scientific Inc.(U.S.)
  • BASF(Germany)
  • Nanotech Energy(U.S.)
  • Advanced Test Equipment Corporation(U.S.)
  • Werfen(Spain)
  • SomaLogic(U.S.)
  • Palamedrix(U.S.)
  • NaNotics LLC(U.S.)
  • Innovasis, Inc.(U.S.)
  • Promimic(U.S.)

結論と提言

目次
Product Code: SQMIG35I2200

Nanomedicine Market size was valued at USD 199.4 billion in 2023 and is poised to grow from USD 224.13 billion in 2024 to USD 570.98 billion by 2032, growing at a CAGR of 12.4% during the forecast period (2025-2032).

The nanomedicine market is poised for significant growth as it focuses on developing innovative solutions that address unmet medical needs and enhance patient outcomes. With advantages such as improved drug delivery, bioavailability, and targeted therapies, nanomedicine leverages advanced nanotechnology to create more precise and personalized treatments. Driving factors include advancements in nanotechnology, which enable novel medical applications, while challenges like high development costs and the complexity of scaling up production must be navigated. Despite these hurdles, the market offers ample opportunities, especially in targeted drug delivery systems and diagnostics amidst the rising prevalence of chronic diseases. Overall, the US nanomedicine market is expected to experience sustainable growth, transforming healthcare delivery through innovative solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nanomedicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nanomedicine Market Segments Analysis

Global Nanomedicine Market is segmented by Product Type, Application, Indication, Modality and region. Based on Product Type, the market is segmented into Nano Molecules, Nanoparticles, Liposomes, Polymer and Polymer Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Nanoshells, Nanotubes and Nanodevices. Based on Application, the market is segmented into Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging,in-vitro diagnostics, Therapeutics and Others. Based on Indication, the market is segmented into Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases and Others. Based on Modality, the market is segmented into Treatment and Diagnostics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nanomedicine Market

The increasing prevalence of chronic illnesses like cancer, cardiovascular diseases, and diabetes significantly propels the growth of the nanomedicine market. This innovative field provides targeted and personalized treatment solutions that not only enhance therapeutic effectiveness but also contribute to better overall patient well-being. By leveraging nanotechnology, healthcare professionals can design treatments that specifically address individual patient needs, leading to more precise interventions. As the demand for advanced medical solutions continues to rise, the role of nanomedicine in improving health outcomes becomes increasingly vital, positioning it as a crucial market driver in the evolving landscape of modern medicine.

Restraints in the Nanomedicine Market

The nanomedicine market faces notable challenges due to the substantial research and development expenses associated with creating and commercializing these products. The intricate manufacturing processes combined with stringent regulatory requirements result in elevated costs that can impede the broader acceptance and adoption of nanomedicine solutions. Consequently, these financial barriers may deter potential investors and limit the number of products that successfully transition from the research phase to market availability, ultimately slowing down advancements in the field and restricting the potential benefits that nanomedicine could bring to healthcare.

Market Trends of the Nanomedicine Market

The nanomedicine market is experiencing significant growth, propelled by the shift towards personalized medicine. By harnessing nanotechnology, healthcare providers can develop targeted therapies that cater to individual patient profiles, optimizing efficacy and minimizing side effects. This trend is becoming increasingly prevalent as advancements in nanotechnology enable precise drug delivery systems, improved diagnostics, and tailored therapies based on genetic and molecular biomarkers. As healthcare systems focus on patient-centric care, the integration of personalized approaches through nanomedicine is set to drive market expansion, fostering innovations and the development of therapeutics that are customized to enhance treatment outcomes in diverse medical conditions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Nanomedicine Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Nano Molecules
  • Nanoparticles
  • Liposomes
  • Polymer and Polymer Drug Conjugates
  • Hydrogel Nanoparticles
  • Dendrimers
  • Nanoshells
  • Nanotubes
  • Nanodevices

Global Nanomedicine Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Vaccines
  • Regenerative Medicines
  • Diagnostic Imaging
  • Drug Delivery
  • Implants
  • In-Vitro Imaging
  • In-Vitro Diagnostics
  • Therapeutics
  • Others

Global Nanomedicine Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Oncological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Orthopedic Disorders
  • Neurological Disorders
  • Urological Disorders
  • Ophthalmological Diseases
  • Immunological Diseases
  • Anti-Inflammatory Diseases
  • Anti-Infective Diseases
  • Others

Global Nanomedicine Market Size by Modality & CAGR (2025-2032)

  • Market Overview
  • Treatment
  • Diagnostics

Global Nanomedicine Market Size & CAGR (2025-2032)

  • North America (Product Type, Application, Indication, Modality)
    • US
    • Canada
  • Europe (Product Type, Application, Indication, Modality)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Application, Indication, Modality)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Application, Indication, Modality)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Application, Indication, Modality)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Imina Technologies SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NANONICS IMAGING Ltd. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Altair Nanotechnologies Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kleindiek Nanotechnik GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • eSpin Technologies, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Nano Products Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Nanotech, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosensors International Group, Ltd. (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanotech Energy (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Test Equipment Corporation (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Werfen (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SomaLogic (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Palamedrix (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NaNotics LLC (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innovasis, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promimic (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations